{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["GABA transporter 1", "N-methyl-(2S,4R)-trans-4-hydroxy-l-proline", "glial fibrillary acidic protein", "ionized calcium-binding adaptor molecule 1", "mesial temporal lobe epilepsy", "neuroprotection", "pilocarpine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32545390", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "25"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "06", "Day": "11"}], "Language": ["eng"], "ELocationID": ["4188", "10.3390/ijms21114188"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "21", "Issue": "11", "PubDate": {"Year": "2020", "Month": "Jun", "Day": "11"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "A Proline Derivative-Enriched Fraction from <i>Sideroxylon obtusifolium</i> Protects the Hippocampus from Intracerebroventricular Pilocarpine-Induced Injury Associated with <i>Status Epilepticus</i> in Mice.", "Abstract": {"AbstractText": ["The <i>N</i>-methyl-(2S,4R)-trans-4-hydroxy-l-proline-enriched fraction (NMP) from <i>Sideroxylon obtusifolium</i> was evaluated as a neuroprotective agent in the intracerebroventricular (icv) pilocarpine (Pilo) model. To this aim, male mice were subdivided into sham (SO, vehicle), Pilo (300 \u00b5g/1 \u00b5L icv, followed by the vehicle <i>per os</i>, <i>po</i>) and NMP-treated groups (Pilo 300 \u00b5g/1 \u00b5L icv, followed by 100 or 200 mg/kg <i>po</i>). The treatments started one day after the Pilo injection and continued for 15 days. The effects of NMP were assessed by characterizing the preservation of cognitive function in both the Y-maze and object recognition tests. The hippocampal cell viability was evaluated by Nissl staining. Additional markers of damage were studied-the glial fibrillary acidic protein (GFAP) and the ionized calcium-binding adaptor molecule 1 (Iba-1) expression using, respectively, immunofluorescence and western blot analyses. We also performed molecular docking experiments revealing that NMP binds to the \u03b3-aminobutyric acid (GABA) transporter 1 (GAT1). GAT1 expression in the hippocampus was also characterized. Pilo induced cognitive deficits, cell damage, increased GFAP, Iba-1, and GAT1 expression in the hippocampus. These alterations were prevented, especially by the higher NMP dose. These data highlight NMP as a promising candidate for the protection of the hippocampus, as shown by the icv Pilo model."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Federal University of Cear\u00e1, Fortaleza 60430-270, Brazil."}], "LastName": "de Aquino", "ForeName": "Pedro Everson Alexandre", "Initials": "PEA"}, {"Identifier": ["0000-0001-6801-7210"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Federal University of Cear\u00e1, Fortaleza 60430-270, Brazil."}], "LastName": "Rabelo Bezerra", "ForeName": "J\u00e9ssica", "Initials": "J"}, {"Identifier": ["0000-0002-0475-2889"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Federal University of Cear\u00e1, Fortaleza 60430-270, Brazil."}], "LastName": "de Souza Nascimento", "ForeName": "Tyciane", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Federal University of Cear\u00e1, Fortaleza 60430-270, Brazil."}], "LastName": "Tavares", "ForeName": "Juliete", "Initials": "J"}, {"Identifier": ["0000-0003-4561-7955"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, 41121 Modena, Italy."}], "LastName": "Rosal Lustosa", "ForeName": "\u00cdtalo", "Initials": "\u00cd"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Federal University of Cear\u00e1, Fortaleza 60430-270, Brazil."}], "LastName": "Chaves Filho", "ForeName": "Adriano Jos\u00e9 Maia", "Initials": "AJM"}, {"Identifier": ["0000-0003-0878-9029"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Molecular Modeling and Drug Design, LabMol, Faculty of Pharmacy, Federal University of Goi\u00e1s, Goi\u00e1s 74605-050, Brazil."}], "LastName": "Mottin", "ForeName": "Melina", "Initials": "M"}, {"Identifier": ["0000-0001-8980-9970"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Federal University of Cear\u00e1, Fortaleza 60430-270, Brazil."}], "LastName": "Mac\u00eado Gaspar", "ForeName": "Danielle", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Federal University of Cear\u00e1, Fortaleza 60430-270, Brazil."}], "LastName": "Andrade", "ForeName": "Geanne Matos de", "Initials": "GM"}, {"Identifier": ["0000-0003-4097-7812"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Federal University of Cear\u00e1, Fortaleza 60430-270, Brazil."}], "LastName": "Tavares Neves", "ForeName": "Kelly Rose", "Initials": "KR"}, {"Identifier": ["0000-0002-7130-2511"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Experimental Epileptology, Department of Biomedical Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41121 Modena, Italy."}, {"Identifier": [], "Affiliation": "Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, 41121 Modena, Italy."}], "LastName": "Biagini", "ForeName": "Giuseppe", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Organic and Inorganic Chemistry, Federal University of Cear\u00e1, Fortaleza 60455-970, Brazil."}], "LastName": "Silveira", "ForeName": "Edilberto Rocha", "Initials": "ER"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Federal University of Cear\u00e1, Fortaleza 60430-270, Brazil."}], "LastName": "de Barros Viana", "ForeName": "Glauce Socorro", "Initials": "GS"}], "GrantList": [{"GrantID": "FAR2018", "Agency": "Universit\u00e0 Degli Studi di Modena e Reggio Emila", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Aif1 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Calcium-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "GABA Plasma Membrane Transport Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Glial Fibrillary Acidic Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Microfilament Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "SLC6A1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Slc6a1 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "glial fibrillary astrocytic protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "trans-4-hydroxy-L-proline"}, {"RegistryNumber": "01MI4Q9DI3", "NameOfSubstance": "Pilocarpine"}, {"RegistryNumber": "RMB44WO89X", "NameOfSubstance": "Hydroxyproline"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Behavior, Animal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Calcium-Binding Proteins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "GABA Plasma Membrane Transport Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glial Fibrillary Acidic Protein"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Hippocampus"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Hydroxyproline"}, {"QualifierName": [], "DescriptorName": "Infusions, Intraventricular"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism"], "DescriptorName": "Microfilament Proteins"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Neurons"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["administration & dosage", "toxicity"], "DescriptorName": "Pilocarpine"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Sapotaceae"}, {"QualifierName": ["chemically induced", "pathology"], "DescriptorName": "Status Epilepticus"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mosh\u00e9 S.L., Perucca E., Ryvlin P., Tomson T. Epilepsy: New advances. Lancet. 2015;385:884\u2013898. doi: 10.1016/S0140-6736(14)60456-6.", "ArticleIdList": ["10.1016/S0140-6736(14)60456-6", "25260236"]}, {"Citation": "GBD 2015 Neurological Disorders Collaborator Group Global, regional, and national burden of neurological disorders during 1990\u20132015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16:877\u2013897. doi: 10.1016/S1474-4422(17)30299-5.", "ArticleIdList": ["10.1016/S1474-4422(17)30299-5", "PMC5641502", "28931491"]}, {"Citation": "Fisher R.S., Acevedo C., Arzimanoglou A., Bogacz A., Cross J.H., Elger C.E., Engel J., Forsgren L., French J.A., Glynn M., et al. ILAE Official Report: A practical clinical definition of epilepsy. Epilepsia. 2014;55:475\u2013482. doi: 10.1111/epi.12550.", "ArticleIdList": ["10.1111/epi.12550", "24730690"]}, {"Citation": "T\u00e9llez-Zenteno J.F., Hern\u00e1ndez-Ronquillo L. A review of the epidemiology of temporal lobe epilepsy. Epilepsy Res. Treat. 2012;2012:1\u20135. doi: 10.1155/2012/630853.", "ArticleIdList": ["10.1155/2012/630853", "PMC3420432", "22957234"]}, {"Citation": "Bl\u00fcmcke I., Thom M., Aronica E., Armstrong D.D., Bartolomei F., Bernasconi A., Bernasconi N., Bien C.G., Cendes F., Coras R., et al. International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: A Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia. 2013;54:1315\u20131329. doi: 10.1111/epi.12220.", "ArticleIdList": ["10.1111/epi.12220", "23692496"]}, {"Citation": "Shorvon S.D. The etiologic classification of epilepsy. Epilepsia. 2011;52:1052\u20131057. doi: 10.1111/j.1528-1167.2011.03041.x.", "ArticleIdList": ["10.1111/j.1528-1167.2011.03041.x", "21449936"]}, {"Citation": "Kwan P., Arzimanoglou A., Berg A.T., Brodie M.J., Hauser W.A., Mathern G., Mosh\u00e9 S.L., Perucca E., Wiebe S., French J. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069\u20131077. doi: 10.1111/j.1528-1167.2009.02397.x.", "ArticleIdList": ["10.1111/j.1528-1167.2009.02397.x", "19889013"]}, {"Citation": "Gilioli I., Vignoli A., Visani E., Casazza M., Canafoglia L., Chiesa V., Gardella E., La Briola F., Panzica F., Avanzini G., et al. Focal epilepsies in adult patients attending two epilepsy centers: Classification of drug-resistance, assessment of risk factors, and usefulness of \u201cnew\u201d antiepileptic drugs. Epilepsia. 2012;53:733\u2013740. doi: 10.1111/j.1528-1167.2012.03416.x.", "ArticleIdList": ["10.1111/j.1528-1167.2012.03416.x", "22360822"]}, {"Citation": "Wiebe S., Jette N. Pharmacoresistance and the role of surgery in difficult to treat epilepsy. Nat. Rev. Neurol. 2012;8:669\u2013677. doi: 10.1038/nrneurol.2012.181.", "ArticleIdList": ["10.1038/nrneurol.2012.181", "22964510"]}, {"Citation": "Beghi E. Addressing the burden of epilepsy: Many unmet needs. Pharmacol. Res. 2016;107:79\u201384. doi: 10.1016/j.phrs.2016.03.003.", "ArticleIdList": ["10.1016/j.phrs.2016.03.003", "26952026"]}, {"Citation": "Greenfield L.J. Molecular mechanisms of antiseizure drug activity at GABAA receptors. Seizure. 2013;22:589\u2013600. doi: 10.1016/j.seizure.2013.04.015.", "ArticleIdList": ["10.1016/j.seizure.2013.04.015", "PMC3766376", "23683707"]}, {"Citation": "Scimemi A. Structure, function, and plasticity of GABA transporters. Front. Cell. Neurosci. 2014;8:1\u201314. doi: 10.3389/fncel.2014.00161.", "ArticleIdList": ["10.3389/fncel.2014.00161", "PMC4060055", "24987330"]}, {"Citation": "Vinet J., Vainchtein I.D., Spano C., Giordano C., Bordini D., Curia G., Dominici M., Boddeke H.W.G.M., Eggen B.J.L., Biagini G. Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus. Glia. 2016;64:1350\u20131362. doi: 10.1002/glia.23008.", "ArticleIdList": ["10.1002/glia.23008", "27246930"]}, {"Citation": "Vinet J., Costa A.-M., Salinas-Navarro M., Leo G., Moons L., Arckens L., Biagini G. A Hydroxypyrone-based inhibitor of metalloproteinase-12 displays neuroprotective properties in both status epilepticus and optic nerve crush animal models. Int. J. Mol. Sci. 2018;19:1\u201316. doi: 10.3390/ijms19082178.", "ArticleIdList": ["10.3390/ijms19082178", "PMC6121268", "30044455"]}, {"Citation": "Setkowicz Z., Kosonowska E., Janeczko K. Inflammation in the developing rat modulates astroglial reactivity to seizures in the mature brain. J. Anat. 2017;231:366\u2013379. doi: 10.1111/joa.12636.", "ArticleIdList": ["10.1111/joa.12636", "PMC5554830", "28597918"]}, {"Citation": "Steward O., Torre E.R., Tomasulo R., Lothman E. Seizures and the regulation of astroglial gene expression. Epilepsy Res. Suppl. 1992;7:197\u2013209.", "ArticleIdList": ["1334663"]}, {"Citation": "Steward O., Kelley M.S., Schauwecker P.E. Signals that regulate astroglial gene expression: Induction of gfap mrna following seizures or injury is blocked by protein synthesis inhibitors. Exp. Neurol. 1997;148:100\u2013109. doi: 10.1006/exnr.1997.6613.", "ArticleIdList": ["10.1006/exnr.1997.6613", "9398453"]}, {"Citation": "Mula M., Sander J.W. Psychosocial aspects of epilepsy: A wider approach. Br. J. Psychiatry Open. 2016;2:270\u2013274. doi: 10.1192/bjpo.bp.115.002345.", "ArticleIdList": ["10.1192/bjpo.bp.115.002345", "PMC4995176", "27703786"]}, {"Citation": "Helmstaedter C., Kockelmann E. Cognitive outcomes in patients with chronic temporal lobe epilepsy. Epilepsia. 2006;47:96\u201398. doi: 10.1111/j.1528-1167.2006.00702.x.", "ArticleIdList": ["10.1111/j.1528-1167.2006.00702.x", "17105474"]}, {"Citation": "Drinovac M., Wagner H., Agrawal N., Cock H.R., Mitchell A.J., von Oertzen T.J. Screening for depression in epilepsy: A model of an enhanced screening tool. Epilepsy Behav. 2015;44:67\u201372. doi: 10.1016/j.yebeh.2014.12.014.", "ArticleIdList": ["10.1016/j.yebeh.2014.12.014", "25625533"]}, {"Citation": "Josephson C.B., Lowerison M., Vallerand I., Sajobi T.T., Patten S., Jette N., Wiebe S. Association of depression and treated depression with epilepsy and seizure outcomes a multicohort analysis. JAMA Neurol. 2017;74:533\u2013539. doi: 10.1001/jamaneurol.2016.5042.", "ArticleIdList": ["10.1001/jamaneurol.2016.5042", "PMC5822203", "28241168"]}, {"Citation": "Van Elst L.T., Woermann F.G., Lemieux L., Thompson P.J., Trimble M.R. Affective aggression in patients with temporal lobe epilepsy: A quantitative MRI study of the amygdala. Brain. 2000;123:234\u2013243. doi: 10.1093/brain/123.2.234.", "ArticleIdList": ["10.1093/brain/123.2.234", "10648432"]}, {"Citation": "Klein S., Bankstahl J.P., L\u00f6scher W., Bankstahl M. Sucrose consumption test reveals pharmacoresistant depression-associated behavior in two mouse models of temporal lobe epilepsy. Exp. Neurol. 2015;263:263\u2013271. doi: 10.1016/j.expneurol.2014.09.004.", "ArticleIdList": ["10.1016/j.expneurol.2014.09.004", "25220610"]}, {"Citation": "Epps S.A., Kahn A.B., Holmes P.V., Boss-Williams K.A., Weiss J.M., Weinshenker D. Antidepressant and anticonvulsant effects of exercise in a rat model of epilepsy and depression comorbidity. Epilepsy Behav. 2013;29:47\u201352. doi: 10.1016/j.yebeh.2013.06.023.", "ArticleIdList": ["10.1016/j.yebeh.2013.06.023", "PMC3783960", "23933912"]}, {"Citation": "Brillatz T., Lauritano C., Jacmin M., Khamma S., Marcourt L., Righi D., Romano G., Esposito F., Ianora A., Queiroz E.F., et al. Zebrafish-based identification of the antiseizure nucleoside inosine from the marine diatom Skeletonema marinoi. PLoS ONE. 2018;13:1\u201315. doi: 10.1371/journal.pone.0196195.", "ArticleIdList": ["10.1371/journal.pone.0196195", "PMC5916873", "29689077"]}, {"Citation": "Bohni N., Cordero-Maldonado M.L., Maes J., Siverio-Mota D., Marcourt L., Munck S., Kamuhabwa A.R., Moshi M.J., Esguerra C.V., de Witte P.A.M., et al. Integration of microfractionation, qNMR and Zebrafish screening for the in vivo bioassay-guided isolation and quantitative bioactivity analysis of natural products. PLoS ONE. 2013;8:1\u201313. doi: 10.1371/journal.pone.0064006.", "ArticleIdList": ["10.1371/journal.pone.0064006", "PMC3660303", "23700445"]}, {"Citation": "Araujo-Neto V., Bomfim R.R., Oliveira V.O.B., Passos A.M.P.R., Oliveira J.P.R., Lima C.A., Mendes S.S., Estevam C.S., Thomazzi S.M. Therapeutic benefits of Sideroxylon obtusifolium (Humb. ex Roem. & Schult.) T.D. Penn., Sapotaceae, in experimental models of pain and inflammation. Rev. Bras. Farmacogn. 2010;20:933\u2013938."}, {"Citation": "Aquino P.E.A., Magalh\u00e3es T.R., Nicolau L.A.D., Leal L.A.K.M.A.M., de Aquino N.C., dos Santos S.M., Neves K.R.T., Silveira E.R., de Barros Viana G.S. The anti-inflammatory effects of N-methyl-(2S,4R)-trans-4-hydroxy-l-proline from Sideroxylon obtusifolium are related to its inhibition of TNF-alpha and inflammatory enzymes. Phytomedicine. 2016;24:14\u201323. doi: 10.1016/j.phymed.2016.11.010.", "ArticleIdList": ["10.1016/j.phymed.2016.11.010", "28160854"]}, {"Citation": "Curia G., Longo D., Biagini G., Jones R.S.G., Avoli M. The pilocarpine model of temporal lobe epilepsy. J. Neurosci. Methods. 2008;172:143\u2013157. doi: 10.1016/j.jneumeth.2008.04.019.", "ArticleIdList": ["10.1016/j.jneumeth.2008.04.019", "PMC2518220", "18550176"]}, {"Citation": "Aquino P.E.A., Paes L.C.F., Costa R.O., Lima L.A.R., Siqueira E.A., Carvalho M.A.J., Cavalcante T.M.B., Silveira E.R., Viana G.S.B. N-methyl-trans-4-hydroxy-l-proline isolated from Sideroxylon obtusifolium leaves has antioxidant and anticonvulsivant activity; Proceedings of the 2nd International Neuroscience Symposium; Fortaleza, Brazil. 18 December 2018."}, {"Citation": "Medina-Ceja L., Pardo-Pe\u00f1a K., Ventura-Mej\u00eda C. Evaluation of behavioral parameters and mortality in a model of temporal lobe epilepsy induced by intracerebroventricular pilocarpine administration. Neuroreport. 2014;25:875\u2013879. doi: 10.1097/WNR.0000000000000207.", "ArticleIdList": ["10.1097/WNR.0000000000000207", "24911387"]}, {"Citation": "Devinsky O., Vazquez B. Behavioral Changes Associated with Epilepsy. Neurol. Clin. 1993;11:127\u2013149. doi: 10.1016/S0733-8619(18)30173-7.", "ArticleIdList": ["10.1016/S0733-8619(18)30173-7", "8441366"]}, {"Citation": "Cornaggia C.M., Beghi M., Provenzi M., Beghi E. Correlation between Cognition and Behavior in Epilepsy. Epilepsia. 2006;47:34\u201339. doi: 10.1111/j.1528-1167.2006.00685.x.", "ArticleIdList": ["10.1111/j.1528-1167.2006.00685.x", "17105457"]}, {"Citation": "Lueptow L.M. Novel object recognition test for the investigation of learning and memory in mice. J. Vis. Exp. 2017;126:1\u20139. doi: 10.3791/55718.", "ArticleIdList": ["10.3791/55718", "PMC5614391", "28892027"]}, {"Citation": "Kraeuter A., Guest P.C., Sarnyai Z. The Y-Maze for Assessment of Spatial Working and Reference Memory in Mice. In: Guest P.C., editor. Pre-Clinical Models: Techniques and Protocols, Methods in Molecular BIOLOGY. Volume 1916. Humana Press; New York, NY, USA: 2019. pp. 105\u2013111.", "ArticleIdList": ["30535688"]}, {"Citation": "Sarhan S., Seiler N. Proline and proline derivatives as anticonvulsants. Gen. Pharmac. 1989;20:53\u201360. doi: 10.1016/0306-3623(89)90060-8.", "ArticleIdList": ["10.1016/0306-3623(89)90060-8", "2707573"]}, {"Citation": "De A., Furtado M., Braga G.K., Oliveira J.A.C., Del Vecchio F., Garcia-Cairasco N. Behavioral, morphologic, and electroencephalographic evaluation of seizures induced by intrahippocampal microinjection of pilocarpine. Epilepsia. 2002;43:37\u201339.", "ArticleIdList": ["12121293"]}, {"Citation": "Furtado M.A., Castro O.W., Del Vecchio F., de Oliveira J.A.C., Garcia-Cairasco N. Study of spontaneous recurrent seizures and morphological alterations after status epilepticus induced by intrahippocampal injection of pilocarpine. Epilepsy Behav. 2011;20:257\u2013266. doi: 10.1016/j.yebeh.2010.11.024.", "ArticleIdList": ["10.1016/j.yebeh.2010.11.024", "21237720"]}, {"Citation": "Lancaster B., Wheal H.V. A comparative histological and electrophysiological study of some neurotoxins in the rat hippocampus. J. Comp. Neurol. 1982;211:105\u2013114. doi: 10.1002/cne.902110202.", "ArticleIdList": ["10.1002/cne.902110202", "6294148"]}, {"Citation": "Victor Nadler J., Cuthbertson G.J. Kainic acid neurotoxicity toward hippocampal formation: Dependence on specific excitatory pathways. Brain Res. 1980;195:47\u201356. doi: 10.1016/0006-8993(80)90865-3.", "ArticleIdList": ["10.1016/0006-8993(80)90865-3", "6249441"]}, {"Citation": "Binder D.K., Carson M.J. Glial cells as primary therapeutic targets for epilepsy. Neurochem. Int. 2013;63:635\u2013637. doi: 10.1016/j.neuint.2013.09.004.", "ArticleIdList": ["10.1016/j.neuint.2013.09.004", "24021493"]}, {"Citation": "Diaz Verdugo C., Myren-Svelstad S., Aydin E., Van Hoeymissen E., Deneubourg C., Vanderhaeghe S., Vancraeynest J., Pelgrims R., IlyasCosacak M., Muto A., et al. Glia-neuron interactions underlie state transitions to generalized seizures. Nat. Commun. 2019;10:1\u201313. doi: 10.1038/s41467-019-11739-z.", "ArticleIdList": ["10.1038/s41467-019-11739-z", "PMC6707163", "31444362"]}, {"Citation": "Yang F., Liu Z.R., Chen J., Zhang S.J., Quan Q.Y., Huang Y.G., Jiang W. Roles of astrocytes and microglia in seizure-induced aberrant neurogenesis in the hippocampus of adult rats. J. Neurosci. Res. 2010;88:519\u2013529. doi: 10.1002/jnr.22224.", "ArticleIdList": ["10.1002/jnr.22224", "19774666"]}, {"Citation": "Schartz N.D., Herr S.A., Madsen L., Butts S.J., Torres C., Mendez L.B., Brewster A.L. Spatiotemporal profile of Map2 and microglial changes in the hippocampal CA1 region following pilocarpine-induced status epilepticus. Sci. Rep. 2016;6:1\u201312. doi: 10.1038/srep24988.", "ArticleIdList": ["10.1038/srep24988", "PMC4855223", "27143585"]}, {"Citation": "Hiragi T., Ikegaya Y., Koyama R., Hiragi T., Ikegaya Y., Koyama R. Microglia after seizures and in epilepsy. Cells. 2018;7:26. doi: 10.3390/cells7040026.", "ArticleIdList": ["10.3390/cells7040026", "PMC5946103", "29597334"]}, {"Citation": "Zhao X., Liao Y., Morgan S., Mathur R., Feustel P., Mazurkiewicz J., Qian J., Chang J., Mathern G.W., Adamo M.A., et al. Noninflammatory changes of microglia are sufficient to cause epilepsy. Cell Rep. 2018;22:2080\u20132093. doi: 10.1016/j.celrep.2018.02.004.", "ArticleIdList": ["10.1016/j.celrep.2018.02.004", "PMC5880308", "29466735"]}, {"Citation": "Shapiro L.A., Wang L., Ribak C.E. Rapid astrocyte and microglial activation following pilocarpine-induced seizures in rats. Epilepsia. 2008;49:33\u201341. doi: 10.1111/j.1528-1167.2008.01491.x.", "ArticleIdList": ["10.1111/j.1528-1167.2008.01491.x", "18226170"]}, {"Citation": "Wyatt-Johnson S.K., Herr S.A., Brewster A.L. Status epilepticus triggers time-dependent alterations in microglia abundance and morphological phenotypes in the hippocampus. Front. Neurol. 2017;8:700. doi: 10.3389/fneur.2017.00700.", "ArticleIdList": ["10.3389/fneur.2017.00700", "PMC5741821", "29326654"]}, {"Citation": "Xu S., Sun Q., Fan J., Jiang Y., Yang W., Cui Y., Yu Z., Jiang H., Li B. role of astrocytes in post-traumatic epilepsy. Front. Neurol. 2019;10:1\u201310. doi: 10.3389/fneur.2019.01149.", "ArticleIdList": ["10.3389/fneur.2019.01149", "PMC6863807", "31798512"]}, {"Citation": "Steward O., Torre E.R., Tomasulo R., Lothman E. Neuronal activity up-regulates astroglial gene expression. Proc. Natl. Acad. Sci. USA. 1991;88:6819\u20136823. doi: 10.1073/pnas.88.15.6819.", "ArticleIdList": ["10.1073/pnas.88.15.6819", "PMC52180", "1862105"]}, {"Citation": "Arisi G.M., Ruch M., Foresti M.L., Mukherjee S., Ribak C.E., Shapiro L.A. Astrocyte alterations in the hippocampus following pilocarpine-induced seizures in aged rats. Aging Dis. 2011;2:294\u2013300.", "ArticleIdList": ["PMC3295071", "22396881"]}, {"Citation": "Coulter D.A., Steinh\u00e4user C. Role of astrocytes in epilepsy. In: Holmes G.L., Noebels J.L., editors. Cold Spring Harbor Perspectives in Medicine. Volume 5. Cold Spring Harbor Laboratory Press; New York, NY, USA: 2015. pp. 1\u201312.", "ArticleIdList": ["PMC4355248", "25732035"]}, {"Citation": "Robel S., Buckingham S.C., Boni J.L., Campbell S.L., Danbolt N.C., Riedemann T., Sutor B., Sontheimer H. Reactive astrogliosis causes the development of spontaneous seizures. J. Neurosci. 2015;35:3330\u20133345. doi: 10.1523/JNEUROSCI.1574-14.2015.", "ArticleIdList": ["10.1523/JNEUROSCI.1574-14.2015", "PMC4339349", "25716834"]}, {"Citation": "Binder D.K., Steinh\u00e4user C. Role of astrocyte dysfunction in epilepsy. In: Stein J., editor. The Curated Reference Collection in Neuroscience and Biobehavioral Psychology. Elsevier; Amsterdan, Holland: 2017. pp. 412\u2013417."}, {"Citation": "Challal S., Bohni N., Buenafe O.E., Esguerra C.V., De Witte P.A.M., Wolfender J.L., Crawford A.D. Zebrafish bioassay-guided microfractionation for the rapid in vivo identification of pharmacologically active natural products. Chimia (Aarau) 2012;66:229\u2013232. doi: 10.2533/chimia.2012.229.", "ArticleIdList": ["10.2533/chimia.2012.229", "22613156"]}, {"Citation": "Schachter S.C. Pharmacology and clinical experience with tiagabine. Expert Opin. Pharmacother. 2001;2:179\u2013187. doi: 10.1517/14656566.2.1.179.", "ArticleIdList": ["10.1517/14656566.2.1.179", "11336578"]}, {"Citation": "Jackson M.F., Esplin B., \u010capek R. Inhibitory nature of tiagabine-augmented GABA (A) receptor-mediated depolarizing responses in hippocampal pyramidal cells. J. Neurophysiol. 1999;81:1192\u20131198. doi: 10.1152/jn.1999.81.3.1192.", "ArticleIdList": ["10.1152/jn.1999.81.3.1192", "10085346"]}, {"Citation": "So E.C., Wu K.C., Kao F.C., Wu S.N. Effects of midazolam on ion currents and membrane potential in differentiated motor neuron-like NSC-34 and NG108-15 cells. Eur. J. Pharmacol. 2014;724:152\u2013160. doi: 10.1016/j.ejphar.2013.12.034.", "ArticleIdList": ["10.1016/j.ejphar.2013.12.034", "24374009"]}, {"Citation": "Vonderlin N., Fischer F., Zitron E., Seyler C., Scherer D., Thomas D., Katus H.A., Scholz E.P. Anesthetic drug midazolam inhibits cardiac human ether-\u00e0-go-go-related gene channels: Mode of action. Drug Des. Devel. Ther. 2015;9:867\u2013877.", "ArticleIdList": ["PMC4338257", "25733807"]}, {"Citation": "Kim D.-S., Kim J.-E., Kwak S.-E., Choi H.-C., Song H.-K., Kimg Y.-I., Choi S.-Y., Kang T.-C. Up-regulated astroglial TWIK-related acid-sensitive K+ channel-1 (TASK-1) in the hippocampus of seizure-sensitive gerbils: A target of anti-epileptic drugs. Brain Res. 2007;1185:346\u2013358. doi: 10.1016/j.brainres.2007.09.043.", "ArticleIdList": ["10.1016/j.brainres.2007.09.043", "17959156"]}, {"Citation": "Hung T.-Y., Huang H.-Y.I., Wu S.-N., Huang C.-W. Depressive effectiveness of vigabatrin (y-Vinyl-GABA), an antiepileptic drug, in intermediate-conductance calcium-sctivated potassium channels in human glioma cells. unpublished.", "ArticleIdList": ["10.21203/rs.3.rs-25157/v1", "PMC7807716", "33441172"]}, {"Citation": "Tescarollo F.C., Rombo D.M., De Liberto L.K., Fedele D.E., Alharfoush E., Tom\u00e9 \u00c2.R., Cunha R.A., Sebasti\u00e3o A.M., Boison D. Role of adenosine in epilepsy and seizures. J. Caffeine Adenosine Res. 2020;00:1\u201316. doi: 10.1089/caff.2019.0022.", "ArticleIdList": ["10.1089/caff.2019.0022", "PMC7301316", "32566903"]}, {"Citation": "Committee for the Update of the Guide for the Care and Use of Laboratory Animals . In: Guide for the Care and Use Oflaboratory Animals. 8th ed. Garber J.C., editor. The National Academies Press; Washington, DC, USA: 2011. pp. 1\u2013208."}, {"Citation": "Murphy N.P., Maidment N.T. Orphanin FQ/Nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J. Neurochem. 2002;73:179\u2013186. doi: 10.1046/j.1471-4159.1999.0730179.x.", "ArticleIdList": ["10.1046/j.1471-4159.1999.0730179.x", "10386969"]}, {"Citation": "Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates. 2nd ed. Academic Press; San Diego, CA, USA: 2001. pp. 1\u2013264."}, {"Citation": "Ferry B., Gervasoni D., Vogt C. Stereotaxic Neurosurgery in Laboratory Rodent\u2014Handbook on Best Practices. 1st ed. Springer; Paris, France: 2014. pp. 1\u2013198."}, {"Citation": "Cavalheiro E.A., Santos N.F., Priel M.R. The pilocarpine model of epilepsy in mice. Epilepsia. 1996;37:1015\u20131019. doi: 10.1111/j.1528-1157.1996.tb00541.x.", "ArticleIdList": ["10.1111/j.1528-1157.1996.tb00541.x", "8822702"]}, {"Citation": "Dix S.L., Aggleton J.P. Extending the spontaneous preference test of recognition: Evidence of object-location and object-context recognition. Behav. Brain Res. 1999;99:191\u2013200. doi: 10.1016/S0166-4328(98)00079-5.", "ArticleIdList": ["10.1016/S0166-4328(98)00079-5", "10512585"]}, {"Citation": "Sarter M., Bodewitz G., Stephens D.N. Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist \u03b2-carbolines. Psychopharmacology (Berl.) 1988;94:491\u2013495. doi: 10.1007/BF00212843.", "ArticleIdList": ["10.1007/BF00212843", "2836875"]}, {"Citation": "Scorza F.A., Arida R.M., Cysneiros R.M., Scorza C.A., Albuquerque M., de Cavalheiro E.A. Estudo qualitativo da forma\u00e7\u00e3o hipocampal de animais hipertensos com epilepsia. Arq. Neuropsiquiatr. 2005;63:283\u2013288. doi: 10.1590/S0004-282X2005000200015.", "ArticleIdList": ["10.1590/S0004-282X2005000200015", "16100975"]}, {"Citation": "Bateman A., Martin M.J., O\u2019Donovan C., Magrane M., Alpi E., Antunes R., Bely B., Bingley M., Bonilla C., Britto R., et al. UniProt: The universal protein knowledgebase. Nucleic Acids Res. 2017;45:D158\u2013D169.", "ArticleIdList": ["PMC5210571", "27899622"]}, {"Citation": "Humphrey W., Dalke A., Schulten K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996;14:33\u201338. doi: 10.1016/0263-7855(96)00018-5.", "ArticleIdList": ["10.1016/0263-7855(96)00018-5", "8744570"]}, {"Citation": "Pagadala N.S., Syed K., Tuszynski J. Software for molecular docking: A review. Biophys. Rev. 2017;9:91\u2013102. doi: 10.1007/s12551-016-0247-1.", "ArticleIdList": ["10.1007/s12551-016-0247-1", "PMC5425816", "28510083"]}, {"Citation": "Hsu S.-M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981;29:577\u2013580. doi: 10.1177/29.4.6166661.", "ArticleIdList": ["10.1177/29.4.6166661", "6166661"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "5", "Day": "23"}, {"Year": "2020", "Month": "6", "Day": "8"}, {"Year": "2020", "Month": "6", "Day": "8"}, {"Year": "2020", "Month": "6", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["32545390", "PMC7312019", "10.3390/ijms21114188", "ijms21114188"]}}], "PubmedBookArticle": []}